|
1
|
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.
|
World J Gastroenterol
|
2007
|
1.77
|
|
2
|
Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.
|
Gastroenterology
|
2004
|
1.27
|
|
3
|
Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection.
|
J Virol
|
2002
|
1.13
|
|
4
|
Calculating the return on investment of mobile healthcare.
|
BMC Med
|
2009
|
1.05
|
|
5
|
Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.
|
Hepatology
|
2004
|
1.02
|
|
6
|
Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation.
|
J Virol
|
2002
|
1.02
|
|
7
|
Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
|
Antimicrob Agents Chemother
|
2008
|
0.99
|
|
8
|
Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
|
Intervirology
|
2002
|
0.97
|
|
9
|
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
|
Antiviral Res
|
2004
|
0.96
|
|
10
|
Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein.
|
J Virol
|
2007
|
0.93
|
|
11
|
Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B.
|
Hepatology
|
2013
|
0.93
|
|
12
|
Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection.
|
Antivir Ther
|
2004
|
0.93
|
|
13
|
Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens.
|
Vaccine
|
2008
|
0.89
|
|
14
|
Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.
|
Hepatology
|
2007
|
0.89
|
|
15
|
Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
|
Antimicrob Agents Chemother
|
2005
|
0.89
|
|
16
|
Kinetics of viremia and acute liver injury in relation to outcome of neonatal woodchuck hepatitis virus infection.
|
J Med Virol
|
2004
|
0.87
|
|
17
|
Clevudine inhibits hepatitis delta virus viremia: a pilot study of chronically infected woodchucks.
|
Antimicrob Agents Chemother
|
2005
|
0.86
|
|
18
|
Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks.
|
Hepatology
|
2010
|
0.84
|
|
19
|
Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.
|
J Virol
|
2011
|
0.82
|
|
20
|
Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection.
|
Hepatology
|
2003
|
0.81
|
|
21
|
Real-time polymerase chain reaction assays for leukocyte CD and cytokine mRNAs of the Eastern woodchuck (Marmota monax).
|
Vet Immunol Immunopathol
|
2002
|
0.80
|
|
22
|
Measurement of cell-mediated immune response in woodchucks.
|
Methods Mol Med
|
2004
|
0.78
|
|
23
|
Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
|
Antimicrob Agents Chemother
|
2007
|
0.76
|